Ignite Creation Date:
2025-12-26 @ 5:22 PM
Ignite Modification Date:
2025-12-29 @ 5:03 AM
Study NCT ID:
NCT00706706
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2008-06-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-25
First Submit QC Date:
None
Study First Post Date:
2008-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-24
Results First Submit QC Date:
None
Results First Post Date:
2012-12-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-14
Last Update Post Date:
2013-01-18
Last Update Post Date Type:
ESTIMATED